Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: May 2019

5/31/2019 Pharmaceutical Drug Import to Russia (March 2019)

Between January and March 2019, Russia imported 125.5 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms (rubles) 8.5% higher than that of the same period in 2018, and 30 bln RUB worth of in-bulk drugs, which is in monetary terms 24.4% higher than that of the same period in 2018. The total dynamics are +11.3% for the period.

5/29/2019 Database Update: Pharmaceutical Drug Production in Russia (April 2019)

Between January and April 2019, Russia produced 127.4 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms (rubles) 26.3% higher than that of the same period in 2018. These high dynamics are due not only to inflation but also to high production volume in physical terms (+4.1%).

5/28/2019 Ranking of Russian Pharmaceutical Distributors (Q1 2019)

Earlier this year, the market saw a renewed growth in monetary terms and the long forgotten double-digit, which looks very impressive in contrast with the moderate results of 2018. However, the dynamics were mostly achieved by the state segment due to the events far from unexpected or inexplicable in the industry. As for retail, the dynamics were just beyond the inflation rates, while the actual demand continues to drop, which is logical due to income decline of the population.

5/24/2019 Database Update: Import of Pharmaceutical Drugs Made in EEU Countries to Russia (April 2019)

Between January and April 2019, Russia imported over 3.6 bln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale prices, VAT included), which is in monetary terms (rubles) 37.8% higher than that of the same period in 2018. In physical terms (units), the dynamics are +46.3%, with 85.4 mln units of pharmaceuticals.